BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 7626553)

  • 1. Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
    Jin JY; Kim DW; Lee JW; Han CW; Min WS; Park CW; Kim CC; Kim DJ; Kim HK; Song HH
    Korean J Intern Med; 1995 Jan; 10(1):25-31. PubMed ID: 7626553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
    Bacigalupo A; Broccia G; Corda G; Arcese W; Carotenuto M; Gallamini A; Locatelli F; Mori PG; Saracco P; Todeschini G
    Blood; 1995 Mar; 85(5):1348-53. PubMed ID: 7532040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
    Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
    Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia.
    Rosenfeld SJ; Kimball J; Vining D; Young NS
    Blood; 1995 Jun; 85(11):3058-65. PubMed ID: 7756640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
    Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
    N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience.
    Zhang XT; Wang X; Cao J; Chen W; Qi KM; Qi N; Liang F; Dong XY; Tang GF; Li DP; Sang W; Li ZY; Cheng H; Xu KL
    Hematology; 2021 Dec; 26(1):1025-1030. PubMed ID: 34895103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe aplastic anemia with sequential immunosuppression.
    Marmont AM; Bacigalupo A; Van Lint MT; Frassoni F; Risso M; Cerri R; Rossi E; Damasio EE; Santini G; Carella M
    Exp Hematol; 1983 Oct; 11(9):856-65. PubMed ID: 6357828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia.
    Gluckman E; Esperou-Bourdeau H; Baruchel A; Boogaerts M; Briere J; Donadio D; Leverger G; Leporrier M; Reiffers J; Janvier M
    J Autoimmun; 1992 Apr; 5 Suppl A():271-5. PubMed ID: 1503621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia.
    Werner EJ; Stout RD; Valdez LP; Harris RE
    Pediatrics; 1989 Jan; 83(1):61-5. PubMed ID: 2642621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin.
    Marmont AM; Bacigalupo A; Van Lint MT; Frassoni F; Podesta M; Reali G; Piaggio G
    Prog Clin Biol Res; 1984; 148():271-87. PubMed ID: 6379665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
    Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antilymphocyte globulin combining with cyclosporine A in the treatment of severe aplastic anemia].
    Zheng Y; Chu Y; Shao Z
    Zhonghua Xue Ye Xue Za Zhi; 1999 Apr; 20(4):175-7. PubMed ID: 11601221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of transfusion-dependent nonsevere aplastic anemia with cyclosporine A plus ATG/ALG versus cyclosporine A plus androgens: a retrospective single center study].
    Song L; Peng GX; Wu ZJ; Zhang L; Jing LP; Zhou K; Li Y; Li Y; Ye L; Li JP; Fan HH; Zhao X; Yang WR; Yang Y; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):946-951. PubMed ID: 27995878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.